Synapse - Works

Results (3719)

Four-year survival update for metastatic melanoma (MM) patients (pts) treated with ipilimumab (IPI) + dacarbazine (DTIC) on phase 3 study CA184-024

Meeting Abstract

Maio, M.; Bondarenko, I.; Robert, C.; Thomas, L.; Garbe, C.; Testori, A.; Francis, S.; Chin, K.; Wolchok, J.
Annals of Oncology (2012)

Fulltext@MSK | Save

Is surgeon's perception of margins during segmentectomy for breast cancer accurate?

Meeting Abstract

Mackey, A.; Feldman, S.; El-Tamer, M.; Sandoval, R.; Hibshoosh, H.; Taback, B.
Annals of Surgical Oncology (2012)

Fulltext@MSK | Save

Five-year survival rates for patients (pts) with metastatic melanoma (MM) treated with ipilimumab (IPI) in phase II trials

Meeting Abstract

Lebbé, C.; Weber, J. S.; Maio, M.; Neyns, B.; Harmankaya, K.; Chin, K.; McDowell, D. O.; Cykowski, L.; McHenry, M. B.; Wolchok, J. D.
Annals of Oncology (2012)

Fulltext@MSK | Save

Ipilimumab (IPI) expanded access program (EAP) for patients (pts) with stage III/IV melanoma: Safety data by subgroups

Meeting Abstract

Lawrence, D.; McDermott, D. F.; Hamid, O.; Weber, J. S.; Wolchok, J. D.; Richards, J.; Amin, A.; Bennett, K.; Balogh, A.; Hodi, F. S.
Annals of Oncology (2012)

Fulltext@MSK | Save

SIOP Pediatric Oncology in Developing Countries (PODC) Abandonment of Treatment Working Group: An evaluation of progress

Meeting Abstract

Lam, C. G.; Tsimicalis, A.; Arreola, M.; Auste, C.; Bagai, P.; Bansal, S.; Chen, H. Y.; Chitalkar, P.; Chittem, M.; Day, S.; more...
Pediatric Blood and Cancer (2012)

Fulltext@MSK | Save

Prognostic importance of etiology in malignant peripheral nerve sheath tumors

Meeting Abstract

LaFemina, J.; Qin, L.; Antonescu, C. R.; Moraco, N. H.; Fields, R. C.; Crago, A. M.; Brennan, M. F.; Singer, S.
Annals of Surgical Oncology (2012)

Fulltext@MSK | Save

Malignant progression in intraductal papillary mucinous neoplasms of the pancreas: Results of 157 patients initially selected for radiographic surveillance

Meeting Abstract

LaFemina, J.; Gaujoux, S.; Kingham, T.; DeMatteo, R. P.; Fong, Y.; D'Angelica, M. I.; Jarnagin, W. R.; Katabi, N.; Do, R. K.; Brennan, M. F.; more...
Annals of Surgical Oncology (2012)

Fulltext@MSK | Save

Dacomitinib (PF-00299804), an irreversible pan-HER tyrosine kinase inhibitor (TKI), for first-line treatment of EGFR-mutant or HER2-mutant or -amplified lung cancers

Meeting Abstract

Kris, M.; Goldberg, Z.; Jänne, P. A.; Kim, D.; Martins, R.; Mok, T. S. K.; O'Connell, J.; Ou, S.; Taylor, I.; Zhang, H.
Annals of Oncology (2012)

Fulltext@MSK | Save

Common breast cancer risk alleles and lobular carcinoma in situ (LCIS)

Meeting Abstract

Koslow, S.; Manschreck, C.; Patil, S.; Vijai, J.; Muhsen, S.; Park, A.; Robson, M.; King, T.
Annals of Surgical Oncology (2012)

Fulltext@MSK | Save

Brivanib (B) in advanced ovarian cancer (OC): Subset results of a phase 2 randomized discontinuation trial (RDT)

Meeting Abstract

Kaye, S. B.; Siu, L. L.; Jassem, J.; Medioni, J.; Soetekouw, Pmmb; Slater, S.; Rudin, C. M.; Schwartz, G. K.; De Jonge, M.; O'Dwyer, P.; more...
Annals of Oncology (2012)

Fulltext@MSK | Save